MRK
105th Edition of the Festival of Stocks
A roundup of last week's stock related blog posts.
How to Play the Uptrend in Biotech With ETFs
Another strong play from medical stock expert Rob Fannon.
How to Profit from the Fall of Big Pharma
So how can you turn a profit in this turbulent sector? By investing in contract research organisations, or CROs, says biotech expert Rob Fannon. When the big pharmaceutical companies outsource research to CROs they get paid whether or not the new drugs ever make it to market.
Dow: An Undervalued 5-Star Market - Seeking Alpha
The 30 stocks in the Dow Jones Industrials are trading for 82% of Morningstar.com's estimated fair value, which makes the Dow an undervalued 5-star market. Eleven of the 30 industrials are undervalued 5-star stocks, according to Morningstar.
I Like Big Moats and I Cannot Lie
A nice discussion of "economic moats" and four ways they are created. However, I don't agree that there are only four types of moats. The article missed at least one other type, toll bridges. I'm surprised Sellers didn't mention that one in his article. Are there any others types missing?
Fat Pitch Financials 2007 Performance
A look back at the performance of the Fat Pitch Financials Portfolio. My 12.22% return was pretty respectable given that the S&P 500 delivered less than half that. This post recaps my trades and current holdings.
November Performance for the Fat Pitch Financials Portfolio
The Fat Pitch Financials Portfolio outperformed the S&P 500 this month as well as the other major indexes. Read the details to see the latest activity in this portfolio.
Bridge Street Journal, Vol. 3.9: WB Loses Lots Fast, and a Good MRK Prediction
- Bridge Street's blog
- Login or register to post comments
- Read more
- 1 point
Merck Sold from the Fat Pitch Financials Port
I made a nice little profit on Merck even though I bought early after the Vioxx news.
October Turnaround for the Fat Pitch Financials Port
The Fat Pitch Financials Port was up 8.35% in October and is currently up 15.19% over the past 12 months. Merck, Microsoft and Unilever were the most interesting positions this month.
Are you really a value investor?
Do you walk the walk of a true value investor
Cheapest Stocks in 16 Years Draw Investors Amid Rout
Seems like everyone is talking about this article on how the stock market is at its cheapest point since 1991. I'm not so sure, but it doesn't really matter anyways if you are examining individual companies.
Fat Pitch Financials Portfolio April 2007 Update
In April, the Fat Pitch Financials Portfolio returned 5.93%. Year-to-date, the portfolio has returned 5.39%. The only major change this month was the addition of Broadridge Financial Solutions to the portfolio on April 10, 2007.
Value Investing: What to Know, Where to Look, and What to Avoid
Excerpt: "We define value investing as the buying of stocks that have fallen in price and are now trading at a discount to their intrinsic value. By using simple valuation techniques and knowing when stock prices have suffered at the hands of irrationality, investors can scoop up bargains and watch stock price regress to normal levels."
Fat Pitch Financials Portfolio Performance Update
The Fat Pitch Financials Portfolio has returned 23.41% since inception (Sept. 21, 2004) at an annualized rate of return of 10.01%. Review the trades of this model portfolio focused on purchasing stocks of wide moat companies trading at prices that provide a significant margin of safety.

